Cardinal Health recently introduced its Flexal Nitrile exam glove that offers the flexibility and barrier protection of a nitrile glove with the tactile sensitivity of a latex one.
Developed in response to customer requests for a strong, comfortable, synthetic glove with the tactility of latex, the Flexal exam glove features a textured-fingertip that provides enhanced sensitivity over traditional nitrile gloves without compromising reliability or durability. As the newest nitrile glove in the Cardinal Health portfolio, Flexal provides a high-quality and cost-effective alternative to latex and nitrile gloves currently available in the market.
"Cardinal Health developed the Flexal Nitrile exam glove to improve a clinicians sense of touch while maintaining confidenc e in its barrier protection," says Lisa Ashby, president of category management for the medical segment of Cardinal Health. "We continue to innovate our product portfolio to provide cost-effective solutions that will help our customers improve the quality of care, and were pleased to offer this alternative in Flexal."
A powder-free addition to Cardinal Healths exam glove portfolio, Flexal complements the Esteem®, Flexam®, InstaGard®, and Triflex® product lines and the Esteem, Duraprene, Protegrity® and Triflex families of Cardinal Health surgical gloves.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.